Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice
-
- Edward A. Stadtmauer
- University of Pennsylvania, Philadelphia, PA, USA
-
- Keith M. Sullivan
- Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA
-
- Mohamed El Idrissi
- GSK, Rue de l’Institut 89, Rixensart, Belgium
-
- Bruno Salaun
- GSK, Rue de l’Institut 89, Rixensart, Belgium
-
- Aránzazu Alonso Alonso
- Hospital Quirón Madrid, Pozuelo de Alarcón, Spain
-
- Charalambos Andreadis
- University of California Medical Center, San Francisco, CA, USA
-
- Veli-Jukka Anttila
- Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
-
- Adrian JC Bloor
- Haematology and Transplant Unit, The Christie NHS Foundation Trust, Manchester, UK
-
- Raewyn Broady
- Vancouver General Hospital, Vancouver, BC, Canada
-
- Claudia Cellini
- U.O. di Ematologia, Ospedale Santa Maria Delle Croci, Ravenna, Italy
-
- Antonio Cuneo
- Unità Operativa di Ematologia, Azienda Osp. Universitaria Arcispedale S. Anna, Cona, Italy
-
- Alemnew F. Dagnew
- GSK, Rockville, MD, USA
-
- Emmanuel Di Paolo
- GSK, Rue de l’Institut 89, Rixensart, Belgium
-
- HyeonSeok Eom
- National Cancer Center, Goyang-si, Republic of Korea
-
- Ana Pilar González-Rodríguez
- Hospital Universitario Central de Asturias, Oviedo, Spain
-
- Andrew Grigg
- Department of Clinical Haematology, Austin Health, Heidelberg, Australia
-
- Andreas Guenther
- Universitaetsklinikum Schleswig-Holstein, Kiel, Germany
-
- Thomas C. Heineman
- Halozyme Therapeutics, San Diego, CA, USA
-
- Isidro Jarque
- Hematology Department & CIBERONC, Instituto Carlos III, Hospital Universitario y Politécnico la fe, Valencia, Spain
-
- Jae-Yong Kwak
- Chonbuk National University Hospital, DukJin-Gu, Republic of Korea
-
- Alessandro Lucchesi
- Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
-
- Lidia Oostvogels
- CureVac AG, Tübingen, Germany
-
- Marta Polo Zarzuela
- Hospital Clínico San Carlos, Madrid, Spain
-
- Anne E. Schuind
- GSK, Rockville, MD, USA
-
- Thomas C. Shea
- Division of Hematology and Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
-
- Ulla Marjatta Sinisalo
- Hematology Unit, Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
-
- Filiz Vural
- Ege University Medical Faculty Hospital, Izmir, Turkey
-
- Lucrecia Yáñez San Segundo
- Hematology Department, Hospital Universitario Marqués De Valdecilla-IDIVAL, University of Cantabria, Santander, Spain
-
- Pierre Zachée
- Hematologie - Oncologie, Ziekenhuisnetwerk Antwerpen - ZNA Stuivenberg & ZNA Middelheim, Antwerpen, Belgium
-
- Adriana Bastidas
- GSK, Wavre, Belgium
Journal
-
- Human Vaccines & Immunotherapeutics
-
Human Vaccines & Immunotherapeutics 17 (11), 4144-4154, 2021-08-18
Informa UK Limited
- Tweet
Details 詳細情報について
-
- CRID
- 1360861711982990080
-
- ISSN
- 2164554X
- 21645515
-
- Data Source
-
- Crossref